An Expanded Cohort Trial of Bortezomib and Sorafenib in Advanced Malignant Melanoma
Clinical trial NCT01078961 · COMPLETED
Trial details
- NCT number
- NCT01078961
- Sponsor
- Massachusetts General Hospital
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2010-09-01
- Primary completion
- 2013-02-01
- Enrollment
- 11
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.